quinazolines has been researched along with cp 31398 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malarz, K; Mularski, J; Musiol, R; Pacholczyk, M | 1 |
| Barmada, SJ; Flores, BN; Green, KM; Ivanova, MI; Kearse, MG; Sheth, UJ; Sutter, AB; Todd, PK; Wright, SE | 1 |
2 other study(ies) available for quinazolines and cp 31398
| Article | Year |
|---|---|
The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Stability; Pyrimidines; Quinazolines; Tumor Suppressor Protein p53 | 2019 |
High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation.
Topics: Amyotrophic Lateral Sclerosis; Animals; Ataxia; Azepines; Cells, Cultured; Circular Dichroism; DNA Repeat Expansion; Drug Evaluation, Preclinical; Fragile X Syndrome; HEK293 Cells; Humans; Neurodegenerative Diseases; Propidium; Pyrimidines; Quinazolines; Rats; Tremor; Trinucleotide Repeat Expansion | 2019 |